The Gist Healthcare Podcast

Gist Healthcare Daily
undefined
Dec 22, 2020 • 6min

Online clinicals leave nursing students feeling unprepared to enter the workforce

Hands-on clinical experience is a key part of training for nurses. But the pandemic has led many facilities to halt in-person clinical rotations to preserve medical supplies and ensure student and patient safety. Howard University nursing students say the lack of in-person training is leaving them feeling unprepared to enter the workforce.  Hosted on Acast. See acast.com/privacy for more information.
undefined
Dec 21, 2020 • 10min

Hospitals see high COVID vaccine interest and low monoclonal antibody treatment uptake

Dr. Jeffrey Stalnaker, Chief Clinical Officer of Rockledge, FL-based Health First, discusses monoclonal antibody treatments for COVID patients, and why uptake has been disappointingly low. Stalnaker also shares his thoughts on vaccine rollout and adoption by health system employees.   Hosted on Acast. See acast.com/privacy for more information.
undefined
Dec 18, 2020 • 9min

Friday, December 18, 2020

An FDA panel recommends the agency approve Moderna’s COVID-19 vaccine for emergency use. And despite pandemic uncertainty, private equity and venture capital deals in healthcare were strong in the third quarter. Dr. Charles Kennedy, CEO of private equity firm Blue Ox Healthcare Partners, expects strong investment in the digital health space to continue into next year.    Hosted on Acast. See acast.com/privacy for more information.
undefined
Dec 17, 2020 • 8min

Thursday, December 17, 2020

Newly released emails from a scientific advisor to the Department of Health and Human Services, show he was pushing a herd immunity strategy for the coronavirus. Pfizer is negotiating a deal with the US government to provide more vaccine doses. And gene-editing technology known as CRISPR is showing promise as a potential cure for sickle-cell anemia.  Hosted on Acast. See acast.com/privacy for more information.
undefined
Dec 16, 2020 • 7min

Wednesday, December 16, 2020

The Food and Drug Administration says Moderna’s vaccine candidate is 94 percent effective. Lawmakers revive a surprise billing fix as part of the year-end spending bill. And newly authorized at-home COVID testing kits could make testing much more convenient. Hosted on Acast. See acast.com/privacy for more information.
undefined
Dec 15, 2020 • 7min

Tuesday, December 15, 2020

The first COVID-19 vaccine doses are being given across the US. Today’s the last day for people to buy a plan on healthcare.gov. And a Wall Street Journal editorial about Jill Biden’s doctorate drew swift criticism as a sexist attack on her credentials. Hosted on Acast. See acast.com/privacy for more information.
undefined
Dec 14, 2020 • 8min

COVID surge forces hospitals turn to travel nurses

As COVID patients flood hospitals in several parts of the country, hospitals turn to healthcare staffing firms to find critical care nurses.  Buffy White, Group President of healthcare staffing firm Cross Country Healthcare discusses how volatile demand for healthcare workers, especially nurses has only exacerbated shortages.    Hosted on Acast. See acast.com/privacy for more information.
undefined
Dec 11, 2020 • 6min

Friday, December 11, 2020

An FDA advisory panel recommends the agency give emergency authorization to the Pfizer and BioNTech COVID vaccine. After a Series C funding round, Cityblock Health is now valued at more than $1 billion. And the Supreme Court upholds an Arkansas law regulating pharmacy middlemen.  Hosted on Acast. See acast.com/privacy for more information.
undefined
Dec 10, 2020 • 10min

Thursday, December 10, 2020

As the country reaches a record of more than 106,000 COVID hospitalizations, some hospital leaders say they're close to reaching crisis standards of care. And one pharmaceutical company is working to bring back a drug for hemophilia patients. Hosted on Acast. See acast.com/privacy for more information.
undefined
Dec 9, 2020 • 8min

Wednesday, December 9, 2020

The first covid shots are given in the United Kingdom. Pfizer and BioNTech's vaccine offers some immunity after the first dose. And Sweden ends its COVID experiment and imposes restrictions. Hosted on Acast. See acast.com/privacy for more information.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app